Artikel mit Open-Access-Mandaten - Alberto AlbaneseWeitere Informationen
GesamtEuropean CommissionNIHGovernment of ItalyDFGMRCFondazione CariploMichael J Fox FoundationNIHRParkinson's Foundation, USATelethonParkinson's UKGovernment of SpainFWFCIHRINSERMZonMwHRBWellcomeBMBFNMRCDoDNHMRCVolkswagenStiftungSFINWOFORTEESRCMotor Neurone Disease Association, UKNRFANRPCORIVinnova, Sweden
Nicht verfügbar: 5
Genome‐wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus?
K Lohmann, A Schmidt, A Schillert, S Winkler, A Albanese, F Baas, ...
Movement Disorders 29 (7), 921-927, 2014
Mandate: Deutsche Forschungsgemeinschaft, Government of Spain, Government of Italy
The dystonias
HA Jinnah
CONTINUUM: Lifelong Learning in Neurology 25 (4), 976-1000, 2019
Mandate: US National Institutes of Health
Quantitative gait analysis in parkin disease: possible role of dystonia
A Castagna, S Frittoli, M Ferrarin, F Del Sorbo, LM Romito, AE Elia, ...
Movement Disorders 31 (11), 1720-1728, 2016
Mandate: European Commission
Post-COVID parkinsonism: A scoping review
P Polverino, A Cocco, A Albanese
Parkinsonism & Related Disorders, 106066, 2024
Mandate: Fondazione Cariplo
Eligibility criteria in clinical trials for cervical dystonia
A Vergallo, A Cocco, T De Santis, S Lalli, A Albanese
Parkinsonism & Related Disorders 104, 110-114, 2022
Mandate: Government of Italy
Verfügbar: 67
Phenomenology and classification of dystonia: a consensus update
A Albanese, K Bhatia, SB Bressman, MR DeLong, S Fahn, VSC Fung, ...
Movement disorders 28 (7), 863-873, 2013
Mandate: US National Institutes of Health, Canadian Institutes of Health Research …
The natural history of multiple system atrophy: a prospective European cohort study
GK Wenning, F Geser, F Krismer, K Seppi, S Duerr, S Boesch, ...
The lancet neurology 12 (3), 264-274, 2013
Mandate: US National Institutes of Health, Fonds zur Förderung der wissenschaftlichen …
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
Mandate: UK Medical Research Council, National Institute for Health Research, UK …
Dystonia: diagnosis and management
A Albanese, M Di Giovanni, S Lalli
European journal of neurology 26 (1), 5-17, 2019
Mandate: Government of Italy
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease?
MG Rizzone, A Fasano, A Daniele, M Zibetti, A Merola, L Rizzi, C Piano, ...
Parkinsonism & related disorders 20 (4), 376-381, 2014
Mandate: Government of Italy
Dystonia rating scales: critique and recommendations
A Albanese, FD Sorbo, C Comella, HA Jinnah, JW Mink, B Post, ...
Movement Disorders 28 (7), 874-883, 2013
Mandate: US National Institutes of Health, Government of Spain
Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review
J Volkmann, A Albanese, A Antonini, KR Chaudhuri, CE Clarke, ...
Journal of neurology 260, 2701-2714, 2013
Mandate: Deutsche Forschungsgemeinschaft, Parkinson's UK, Netherlands Organisation …
A genome-wide association study in multiple system atrophy
A Sailer, SW Scholz, MA Nalls, C Schulte, M Federoff, TR Price, A Lees, ...
Neurology 87 (15), 1591-1598, 2016
Mandate: US National Institutes of Health, Fondazione Telethon, Italy, UK Medical …
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
GU Höglinger, I Litvan, N Mendonca, D Wang, H Zheng, ...
The Lancet Neurology 20 (3), 182-192, 2021
Mandate: US National Institutes of Health, Deutsche Forschungsgemeinschaft …
GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort
S Petrucci, M Ginevrino, I Trezzi, E Monfrini, L Ricciardi, A Albanese, ...
Movement Disorders 35 (11), 2106-2111, 2020
Mandate: UK Medical Research Council, Fondazione Cariplo, European Commission …
Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up
P Amami, I Dekker, S Piacentini, F Ferré, LM Romito, A Franzini, ...
Journal of Neurology, Neurosurgery & Psychiatry 86 (5), 562-564, 2015
Mandate: Government of Italy
Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin
MF Contarino, J Van Den Dool, Y Balash, K Bhatia, N Giladi, JH Koelman, ...
Frontiers in neurology 8, 35, 2017
Mandate: European Commission
Treatable inherited rare movement disorders
HA Jinnah, A Albanese, KP Bhatia, F Cardoso, G Da Prat, TJ de Koning, ...
Movement Disorders 33 (1), 21-35, 2018
Mandate: US National Institutes of Health, Canadian Institutes of Health Research …
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement
A Albanese, G Abbruzzese, D Dressler, W Duzynski, S Khatkova, MJ Marti, ...
Journal of neurology 262, 2201-2213, 2015
Mandate: National Institute of Health and Medical Research, France
Inclusion and exclusion criteria for DBS in dystonia
H Bronte‐Stewart, T Taira, F Valldeoriola, M Merello, WJ Marks Jr, ...
Movement disorders 26 (S1), S5-S16, 2011
Mandate: US National Institutes of Health, Canadian Institutes of Health Research
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt